Patient Education Blog

Highlights of the 2013 ASH Annual Meeting

Stephan Moll, MD writes… The annual meeting of the American Society of Hematology (ASH) took place this month (Dec 6-12th, 2013) in New Orleans. Relatively few new data about blood clots and blood thinners that have an impact on clinical management were presented. I found no practice-changing abstract. The clinically relevant highlights, summarized for health care professionals, are discussed here.

Disclosure:  I have been a consultant for  Boehringer-Ingelheim, Daiichi, Janssen, and CSL Behring.

Last Updated:  Dec 31st, 2013

Tags: , ,

This entry was posted by clotconnect on at and is filed under Other topics. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.